Amla Fruit Extract and Vitamin C in Bio C: An Ingredient-Based Narrative Review of Phytochemistry, Antioxidant Mechanisms and Domain-Specific Evidence
Keywords:
Phyllanthus emblica, amla, vitamin C, hydrolysable tannins, antioxidant, nutraceutical claim substantiationAbstract
Background. Oxidative stress contributes to cellular damage across many tissues. Phyllanthus emblica L. (amla; Phyllanthaceae) fruit is distinctive in combining ascorbate with a hydrolysable tannin fraction — emblicanin A, emblicanin B, punigluconin and pedunculagin — whose antioxidant activity exceeds the contribution of the fruit’s vitamin C alone.
Objective. To appraise the phytochemistry, antioxidant mechanisms and domain-specific evidence relevant to Bio C, which supplies 900 mg of dried amla fruit extract with 80 mg of vitamin C per serving, separating ingredient-level from finished-product evidence throughout.
Review approach. PubMed, Web of Science, Scopus, Google Scholar and the Cochrane Library were searched for systematic reviews, randomised trials, pharmacokinetic studies and mechanistic reports, each graded against a five-tier hierarchy ending in product-specific evidence.
Principal findings. The antioxidant and metabolic domain is most mature: randomised trials of standardised extract lowered malondialdehyde and raised nitric oxide and glutathione at 250–500 mg twice daily, reduced 8-hydroxy-2′-deoxyguanosine at 500 mg/day, and improved the lipid profile over 12 weeks, with a meta-analysis of nine trials reporting lipid and inflammatory benefit that its authors qualified for substantial heterogeneity. A double-blind placebo-controlled trial of amla monotherapy at 2000 mg/day reduced heartburn and regurgitation in non-erosive reflux disease. Skin and hair rest on mechanistic work with an oral randomised trial of a lingonberry–amla combination and an uncontrolled topical serum study. Ocular relevance is confined to ascorbate physiology; the AREDS base requires 500 mg vitamin C with vitamin E, zinc, copper and carotenoids and is not transferable.
Limitations. Finished-product randomised trials are largely absent across this category, so the appraisal is ingredient-level; extract chemistry varies widely, making marker standardisation the principal quality requirement.
Conclusion. Within the Food Safety and Standards Authority of India framework, supplements of this composition are well positioned for daily antioxidant and nutritional support, with the digestive, hair, skin and eye associations communicable as documented in Ayurvedic traditional use. Disease-specific claims remain a separate category requiring product-specific trials.
Published
Issue
Section

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

